Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  American Journal of Public Health

• Publication date

  2002-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2105/AJPH.92.10.1606PMID 12356606PMCID PMC1447292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Herbal medicines and perioperative care

  2001cited by this paper
• The Prevalence and Predictors of the Use of Alternative Medicine in Presurgical Patients in Five California Hospitals

  2001cited by this paper
• A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients

  2001cited by this paper
• Determinants of the use of complementary therapies by patients with cancer.

  2001cited by this paper
• Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy

  2000cited by this paper
• Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.

  2000cited by this paper
• Ethnic Differences in Complementary and Alternative Medicine Use Among Cancer Patients

  2000cited by this paper
• Use of complementary medicine by adult patients participating in cancer clinical trials.

  2000cited by this paper
• Alternative therapies used by women with breast cancer in four ethnic populations.

  2000cited by this paper
• Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer.

  1999cited by this paper
• Use of complementary and alternative medicine in Hawaii cancer patients.

  1999cited by this paper
• Disclosing complementary and alternative medicine use in the medical encounter: a qualitative study in women with breast cancer.

  1999cited by this paper
• Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis.

  1999cited by this paper
• Alternative medicine use in patients with localized prostate carcinoma treated with curative intent

  1999cited by this paper
• Dietary supplement-drug interactions.

  1999cited by this paper
• Use of alternative medicine by women with early-stage breast cancer.

  1999cited by this paper
• Dietary supplement-drug interactions.

  1999cited by this paper
• How expectancies shape experience.

  1999cited by this paper
• Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.

  1998cited by this paper
• Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate Cancer

  1998cited by this paper
• The use of complementary therapies by breast cancer patients attending conventional treatment.

  1998cited by this paper
• Why patients use alternative medicine: results of a national study.

  1998cited by this paper
• Complementary Medicine: A Research Perspective

  1997cited by this paper
• Development and validation of brief measures of positive and negative affect: the PANAS scales.

  1988cited by this paper

• Six Patterns of Homeopathy Use in Integrative Oncology: A Qualitative Study (TOUCAN)

  2024cites this paper
• Exploring Integrative Approaches: Insights Into Complementary Medicine Practices Among Breast Cancer Survivors in Saudi Arabia

  2024cites this paper
• Disparities in chiropractic utilization by race, ethnicity and socioeconomic status: A scoping review of the literature.

  2023cites this paper
• Advances in Molecular Regulation of Prostate Cancer Cells by Top Natural Products of Malaysia

  2023cites this paper
• Complementary and alternative medicine for urinary tract illnesses: A cross-sectional survey in Jordan.

  2021cites this paper
• Use of Complementary and Alternative Medicine among Breast Cancer Women in Jordan

  2020cites this paper
• The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia

  2018cites this paper
• Factors associated with the use of complementary and alternative medicines for prostate cancer by long-term survivors

  2018cites this paper
• The relationship between anxiety about prostate cancer among patients with biochemical cancer recurrence and the use of complementary and alternative medicines, diet, and exercise

  2017cites this paper
• In vitro pro-apoptotic and anti-migratory effects of Marantodes pumilum (Blume) Kuntze and Ficus deltoidea L. extracts on prostate cancer cell lines

  2017cites this paper
• The Janus-Faced Role of Antioxidants in Cancer Cachexia: New Insights on the Established Concepts

  2016cites this paper
• Saw Palmetto for Symptom Management During Radiation Therapy for Prostate Cancer.

  2016cites this paper
• Mechanisms and therapeutic effectiveness of pulsed electromagnetic field therapy in oncology

  2016cites this paper
• Complementary and Alternative Medicine Approaches for Pain in Underserved Chinese-American Cancer Patients: Prevalence and Correlates.

  2016cites this paper
• Complementary and Alternative Medicine (CAM) Disclosure to the Health Care Providers: A Qualitative Insight from Malaysia Thalassemia Patients

  2016cites this paper
• Understanding the use and disclosure of natural products by cancer patients

  2016cites this paper
• Interpersonal factors impacting the decision to (continue to) use complementary and alternative medicine (CAM) in men with cancer: a mixed-methods study.

  2014cites this paper
• Complementary and alternative medicine use in patients with mental disorders in Turkey.

  2013cites this paper
• Chapter 8 A Glance at the Complexity of Nutrition and the Prostate : Considering Molecular Targets to Unravel the Most Recent Controversy Between Omega-3 Fatty Acids and Their Impact on Prostate Cancer Risk

  2013cites this paper
• A Glance at the Complexity of Nutrition and the Prostate: Considering Molecular Targets to Unravel the Most Recent Controversy Between Omega-3 Fatty Acids and Their Impact on Prostate Cancer Risk

  2013cites this paper
• Use of complementary medications among older adults with cancer

  2012cites this paper
• Title Isoflavones in treating watchful waiting benign prostatehyperplasia : a double-blinded , randomized controlled trial

  2012cites this paper
• Complementary and alternative medicines (CAM) disclosure to the health care providers: a qualitative insight from Malaysian cancer patients.

  2012cites this paper
• Prevalence and predictors of complementary and alternative medicine (CAM) use by men in Australian cancer outpatient services.

  2012cites this paper
• How Many Cancer Patients Use Complementary and Alternative Medicine

  2012cites this paper
• Isoflavones in Treating Watchful Waiting Benign Prostate Hyperplasia: A Double-Blinded, Randomized Controlled Trial

  2012cites this paper
• Complementary and alternative therapies for urinary symptoms: use in a diverse population sample qualitative study.

  2012cites this paper
• Family and Complementary and Alternative Medicine

  2011cites this paper
• Use of Acupuncture Among Patients with Prostate Cancer Covered by National Health Insurance in Taiwan: A Retrospective Population-Based Study

  2011cites this paper
• Trends in Chinese Medicine Use Among Prostate Cancer Patients Under National Health Insurance in Taiwan

  2011cites this paper
• Práticas alternativas e complementares no tratamento do câncer: revisão integrativa da literatura

  2011cites this paper
• Use of Chinese medicine by cancer patients: a review of surveys

  2011cites this paper
• International Utilisation of Complementary Medical Approaches

  2011cites this paper
• Complementary and alternative medicine use among newly diagnosed prostate cancer patients

  2010cites this paper
• Herbal Product–Drug Interactions from a Pharmacological Perspective

  2010cites this paper
• Polypharmacy in older adults with cancer.

  2010cites this paper
• Prevalence, Patterns, and Costs of Chinese Medicine Use Among Prostate Cancer Patients: A Population-Based Study in Taiwan

  2010cites this paper
• Evaluation of the anticancer potential of plants used as traditional medicines by Aboriginal people

  2010cites this paper
• Use of complementary and alternative medicine for treatment among African-Americans: a multivariate analysis.

  2010cites this paper
• Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies

  2010cites this paper
• Quality of Life and Patterns of Use of Complementary and Alternative Medicines Among Glioma Patients.

  2009cites this paper
• Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals.

  2009cites this paper
• Prostate tumor growth can be modulated by dietarily targeting the 15-lipoxygenase-1 and cyclooxygenase-2 enzymes.

  2009cites this paper
• A Multivariate Test of an Expanded Andersen Health Care Utilization Model for Complementary and Alternative Medicine (CAM) Use in African Americans

  2009cites this paper
• Sociocultural in aging men's health: implications and recommendations for the clinician

  2009cites this paper
• Sociocultural considerations in aging men's health: implications and recommendations for the clinician

  2009cites this paper
• Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review.

  2008cites this paper
• Nutraceuticals in Prostate Disease: The Urologist's Role.

  2008cites this paper
• The use of complementary therapy by men with prostate cancer in the UK.

  2008cites this paper
• Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

  2007cites this paper
• Integrative Oncology Practice Guidelines.

  2007cites this paper
• Complementary and alternative medicine modality use and beliefs among African American prostate cancer survivors.

  2007cites this paper
• Integrative Oncology Practice Guidelines.

  2007cites this paper
• Racial Differences in Prostate Cancer Mortality

  2007cites this paper
• Patterns of Complementary and Alternative Medicine Use in African Americans

  2007cites this paper
• Age, Ethnicity, and Use of Complementary and Alternative Medicine in Health Self-Management∗

  2007cites this paper
• Complementary and Alternative Medicine Use Among Hispanics in the United States

  2007cites this paper
• Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies

  2007cites this paper
• A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group.

  2007cites this paper
• Complementary and alternative medicine (CAM) and supportive care in cancer: a synopsis of research perspectives and contributions by an interdisciplinary team

  2007cites this paper
• The impact of acculturation on the use of traditional Chinese medicine in newly diagnosed Chinese cancer patients

  2007cites this paper
• Complementary and alternative medicine use and quality of life in patients with primary brain tumors.

  2006cites this paper
• Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy.

  2006cites this paper
• Prostate Tumor Growth and Recurrence Can Be Modulated by the ω-6:ω-3 Ratio in Diet: Athymic Mouse Xenograft Model Simulating Radical Prostatectomy

  2006cites this paper
• Complementary and alternative medicine during cancer treatment: beyond innocence.

  2006cites this paper
• Prevalence of traditional Chinese medicine and other complementary and alternative medicine use among Chinese cancer patients in British Columbia, Canada

  2006cites this paper
• Gaining insight into the what, why and where of complementary and alternative medicine use by cancer patients and survivors.

  2006cites this paper
• Integrative oncology: tapping into a research goldmine.

  2006cites this paper
• The yin and yang of 15-lipoxygenase-1 and delta-desaturases: Dietary omega-6 linoleic acid metabolic pathway in prostate

  2006cites this paper
• Assessing the effects of race and ethnicity on use of complementary and alternative therapies in the USA

  2005cites this paper
• Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer.

  2005cites this paper
• The Experience of Indigenous Traditional Healing and Cancer

  2004cites this paper
• Utilization of Complementary and Alternative Medicine Among Racial and Ethnic Minority Populations: Implications for Reducing Health Disparities

  2004influential citation
• Complementary and alternative therapies for cancer.

  2004cites this paper
• Equiguard suppresses androgen-dependent LNCaP prostate cancer cell proliferation by targeting cell cycle control via down regulation of the retinoblastoma protein Rb and induction of apoptosis via the release of cytochrome c.

  2004cites this paper
• Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer

  2004cites this paper
• Complementary and alternative medicine use by patients enrolled onto phase I clinical trials.

  2004cites this paper
• TABLE 2—Pearson Product-Moment Correlations Between Changes in Outcome Variables and Baseline Measures

  2002cites this paper
• F AMILY AND COMPLEMENTARY AND ALTERNATIVE MEDICINE

  year unknowncites this paper